306 related articles for article (PubMed ID: 19122110)
1. Q: Who should receive the shingles vaccine?
Singh A; Englund K
Cleve Clin J Med; 2009 Jan; 76(1):45-8. PubMed ID: 19122110
[No Abstract] [Full Text] [Related]
2. Why should older adults receive the shingles vaccine?
Harkness TL
J Gerontol Nurs; 2010 Oct; 36(10):51-5. PubMed ID: 20506935
[TBL] [Abstract][Full Text] [Related]
3. Zoster vaccine live.
Kockler DR; McCarthy MW
Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia.
Brisson M; Pellissier JM; Levin MJ
Clin Infect Dis; 2007 Dec; 45(11):1527-9. PubMed ID: 17990240
[No Abstract] [Full Text] [Related]
5. Varicella-zoster vaccine for the prevention of herpes zoster.
Kimberlin DW; Whitley RJ
N Engl J Med; 2007 Mar; 356(13):1338-43. PubMed ID: 17392303
[No Abstract] [Full Text] [Related]
6. Varicella-zoster vaccine.
Senanayake SN
N Engl J Med; 2007 Jul; 357(1):89-90. PubMed ID: 17615639
[No Abstract] [Full Text] [Related]
7. Taking a shot at shingles.
Johns Hopkins Med Lett Health After 50; 2012 Aug; 24(7):8. PubMed ID: 23033561
[No Abstract] [Full Text] [Related]
8. Zoster vaccine in older adults.
Fried R
J Am Geriatr Soc; 2010 Sep; 58(9):1799-800. PubMed ID: 20863342
[No Abstract] [Full Text] [Related]
9. Herpes zoster vaccine brings relief for the elderly.
Morrow T
Manag Care; 2006 Dec; 15(12):57-8. PubMed ID: 17260848
[No Abstract] [Full Text] [Related]
10. Shingles vaccination is likely to be cost effective at age 65 or 70.
Dobson R
BMJ; 2009 Mar; 338():b944. PubMed ID: 19270023
[No Abstract] [Full Text] [Related]
11. A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus.
Bharucha T; Ming D; Breuer J
Hum Vaccin Immunother; 2017 Aug; 13(8):1789-1797. PubMed ID: 28426274
[TBL] [Abstract][Full Text] [Related]
12. [Herpes zoster and postherpetic neuralgia: advantages of the vaccination].
Cañada JL
Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():19-21. PubMed ID: 20084344
[No Abstract] [Full Text] [Related]
13. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
Lu PJ; Euler GL; Jumaan AO; Harpaz R
Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
[TBL] [Abstract][Full Text] [Related]
14. Varicella virus and the herpes zoster vaccine. A review of Zostavax and the new AFIP recommendations.
Ebede TL; Zippin JH
J Drugs Dermatol; 2008 Dec; 7(12):1173-6. PubMed ID: 19137773
[No Abstract] [Full Text] [Related]
15. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
Lu PJ; Euler GL; Harpaz R
Am J Prev Med; 2011 Feb; 40(2):e1-6. PubMed ID: 21238856
[TBL] [Abstract][Full Text] [Related]
16. The immunogenicity and safety of zoster vaccine in Taiwanese adults.
Yao CA; Chen LK; Huang KC
Vaccine; 2015 Mar; 33(13):1515-7. PubMed ID: 25681662
[TBL] [Abstract][Full Text] [Related]
17. Shingrix--an adjuvanted, recombinant herpes zoster vaccine.
Med Lett Drugs Ther; 2017 Dec; 59(1535):195-196. PubMed ID: 29186082
[No Abstract] [Full Text] [Related]
18. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium.
Bilcke J; Marais C; Ogunjimi B; Willem L; Hens N; Beutels P
Vaccine; 2012 Jan; 30(3):675-84. PubMed ID: 22120193
[TBL] [Abstract][Full Text] [Related]
19. Vaccination to prevent herpes zoster and postherpetic neuralgia.
Oxman MN
Hum Vaccin; 2007; 3(2):64-8. PubMed ID: 17299270
[No Abstract] [Full Text] [Related]
20. Immune senescence and vaccines to prevent herpes zoster in older persons.
Levin MJ
Curr Opin Immunol; 2012 Aug; 24(4):494-500. PubMed ID: 22857823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
